

					

						November 8, 2017 - By Louis Casey
 The stock of Shire Plc Ads (NASDAQ:SHPG) registered an increase of 32.5% in short interest. SHPG’s total short interest was 1.54 million shares in November as published by FINRA. Its up 32.5% from 1.16M shares, reported previously. With 1.34M shares average volume, it will take short sellers 1 days to cover their SHPG’s short positions. The short interest to Shire Plc Ads’s float is 0.52%. About 174,720 shares traded. Shire PLC (ADR) (NASDAQ:SHPG) has risen 4.69% since November 8, 2016 and is uptrending. It has underperformed by 12.01% the S&P500.Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The company has market cap of $43.70 billion. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It has a 26.91 P/E ratio. It focuses its development resources on projects in various therapeutic areas , including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.Among 25 analysts covering Shire plc (ADR) (NASDAQ:SHPG), 21 have Buy rating, 0 Sell and 4 Hold. Therefore 84% are positive. Shire plc (ADR) had 56 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Friday, October 27. The stock of Shire PLC (ADR) (NASDAQ:SHPG) earned “Buy” rating by Jefferies on Friday, June 3. The rating was upgraded by Bank of America on Monday, January 18 to “Buy”. The stock of Shire PLC (ADR) (NASDAQ:SHPG) has “Outperform” rating given on Tuesday, November 17 by Leerink Swann. The stock of Shire PLC (ADR) (NASDAQ:SHPG) earned “Buy” rating by RBC Capital Markets on Wednesday, June 7. The rating was maintained by Piper Jaffray with “Hold” on Friday, September 29. As per Thursday, August 6, the company rating was downgraded by Exane. The stock of Shire PLC (ADR) (NASDAQ:SHPG) earned “Buy” rating by Jefferies on Friday, June 9. The rating was maintained by RBC Capital Markets with “Buy” on Monday, July 10. On Tuesday, June 28 the stock rating was maintained by Goldman Sachs with “Buy”.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
<!-- google_ad_client = "ca-pub-7620071422727774"; /* weeklyregister.com_300x600 */ google_ad_slot = "8032669457/1411802476/1313492366"; google_ad_width = 300; google_ad_height = 600; //-->


